A year of change

Monday 4 February 2019

A lot can change in a year. So today on World Cancer Day we're proudly reflecting on all that's happened in the last 12 months, the progress we've made, and all that you've helped to achieve.

United, we took a stand

This time last year, we were campaigning for the national roll out of 5-ALA (the 'pink drink'). With the support of the late Baroness Tessa Jowell, and neurosurgeons Stephen Price, Colin Watts and Pablo Goetz, in 2018 we reached success.

The Government committed to the national roll out of 5-ALA and in July, we saw new NICE (National Institute for Health and Care Excellence) guidelines published on its use. The new NHS Long Term Plan, released in January 2019, has also confirmed this.

We funded a first

In the last 12 months, we've committed £2.8 million towards The Tessa Jowell BRAIN-MATRIX, a first-of-its kind clinical trial. The trial is helping advance a cure for glioma brain tumours, testing new potential treatments as they become available.

The novel, adaptive design will also allow researchers to add new 'arms', speeding up progress and accelerating towards a cure.

We're helping more people get the right support

Last year, we were funding one clinical nurse specialist – Charlotte Robinson at King's College Hospital, London. Now, we're proud to fund two more in the last 12 months - Kelly Dawson at Nottingham University Hospitals NHS Trust and Julie Collins at the Edinburgh Centre for Neuro Oncology.

Access to a CNS can have a positive impact on people's experience of diagnosis and treatment for a brain tumour, so funding more is an exciting step towards giving more people the support they need.

We found our first Future Leader

In the last 12 months, we were proud to introduce our first Future Leader of research - post-doctoral researcher, Dr Laure Bihannic.

Dr Bihannic was awarded our grant of £180,000 to investigate the childhood brain tumour, medulloblastoma. Laure and her team hope to gain a deeper understanding of medulloblastoma subtypes, Groups 3 and 4, and develop better, targeted treatments.

Together, we reached a milestone

In 2018 we celebrated a huge milestone. We reached our goal of committing £20 million to research two years ahead of schedule. Research is the key to propelling our understanding and beating brain tumours once and for all.

Yet less than 2% of cancer research funding goes towards brain tumours, so this immense investment is helping us make headway.

And we'll keep doing more for a cure. We're going further, faster, making more progress than ever before. The last 12 months - and every month before them - would not have been possible without you. Thank you for your dedication and support. Let's see what the next 12 months will hold!

We promise to keep your data safe and you can unsubscribe at any time in the future. More information is in our Privacy Policy.